Retatrutide
Triple agonist peptide (GLP-1/GIP/Glucagon) for cutting-edge metabolic research.
Product information
- Catalog purity specification
- 99%+
- form
- Lyophilized Powder
- Availability
- In stock
Price and options
- Retatrutide — 5mg: USD $105.00 — In stock
- Retatrutide — 10mg: USD $190.00 — In stock
- Retatrutide — 20mg: USD $320.00 — In stock
- Retatrutide — 40mg: USD $399.00 — In stock
- Retatrutide — 60mg: USD $640.00 — In stock
Research-use disclaimer
For laboratory research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Product testing documentation
Research information
Retatrutide Research Review: A Triple GLP-1/GIP/Glucagon Receptor Agonist for Metabolic Studies
A research-focused overview of Retatrutide, a unified triple agonist of the GLP-1, GIP, and glucagon receptors studied for its incretin and glucagon-arm mechanisms, weekly pharmacokinetics, and metabolic and body-composition research endpoints.
Certificates of Analysis and supporting laboratory documentation